Tribune Therapeutics AB
559281-1045ActiveDeveloping novel medicines to halt fibrotic disease progression across organs.
Oversikt
- 1–4
- Ansatte
- ≤1t SEK
- Omsetning
- 2020
- Grunnlagt
Nøkkelbeslutningstakere
Georg Vo Beiske
CEO
Ole J. Kaasbøll
CSO, Co-founder
Berthold Bödeker
CTO
Mathias Locher
CDO
Beskrivelse
Tribune Therapeutics is a preclinical biopharmaceutical company established in 2020, focused on creating novel medicines for treating fibrosis. Their core mission is to address fibrotic diseases regardless of the underlying cause or affected tissue, such as the heart, kidneys, or lungs. The company'...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559281104501
Beslutningstakere
4 kontakter i FunnelfeedrGeorg Vo Beiske
CEO
Ole J. Kaasbøll
CSO, Co-founder
Berthold Bödeker
CTO
Mathias Locher
CDO
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAQILION AB
5–9 ansatteDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
CALLUNA PHARMA AS
10 ansatteClinical stage biotech pioneering antibodies for inflammation and fibrosis.
CANTARGIA AB
20–49 ansatteDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
PILA PHARMA AB
1–4 ansatteClinical stage biotech developing an oral obesity and diabetes treatment.
AcroPharma AB (publ)
0 ansatteDeveloping innovative preventive therapeutics for major human diseases.
Utforsk mer
Spørsmål om Tribune Therapeutics AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo